KARRAH DE LA FUENTE: Open Payments
NPI 1518389980 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 42 payments from 13 companies in 2025. Trend: 2023 $1,233 · 2024 $52 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $222 |
| Novo Nordisk Inc | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| SANOFI-AVENTIS U.S. LLC | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Dexcom, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $31 |
| Abbott Laboratories | 1 | $22 |
Products named: JARDIANCE, TZIELD, Dexcom G6 Transmitter, MOUNJARO, PREVNAR 20, Rybelsus, Wegovy, BREZTRI.
Industry payments across TX — which companies pay providers there.
